MedPath

Effect of cinnamon in the treatment of Helicobacter Pylori

Phase 2
Conditions
helicobacter pylori B98.0.
Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Registration Number
IRCT201505032276N2
Lead Sponsor
Vice Chancellor for Research, Qazvin University of Medical Sciences and Health Servises
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
152
Inclusion Criteria

Patients with dyspepsia; nosea; vomiting; epigastric pain attending gastrointestinal clinic of Velayat hospital and infectious diseases clinic of Bualisina hospital with positive evidense of Helicobacter Pylori infection (stool antigen test).
Exclusion criteria: HIV infection; known cases of malignancies.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
egative result of stool antigen of Helicobacter Pylori. Timepoint: 6 weeks after the end of treatment. Method of measurement: Checking of H.Pylori stool antigen.
Secondary Outcome Measures
NameTimeMethod
Oral ulcer. Timepoint: During, end and till 6 weeks after end of treatment. Method of measurement: Patient report.;Epigasteric pain. Timepoint: During, end and till 6 weeks after end of treatment. Method of measurement: Patient report.;Skin rash. Timepoint: During, end and till 6 weeks after end of treatment. Method of measurement: Patient report.;Diarrhea. Timepoint: During, end and till 6 weeks after end of treatment. Method of measurement: Patient report.
© Copyright 2025. All Rights Reserved by MedPath